Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:29682102

Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer.

Junjeong Choi · Eun-Sol Kim · Ja Seung Koo

Disease markers · 2018 doi:10.1155/2018/9369358

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:29682102
kind
science-record
content_hash
sha256:9eb2584f04abb9d54d131e7aa911914c9679d989a9e4250a953fcae48df649bb
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:33Z
updated_at
2026-11-01T21:59:48Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer.
doi
10.1155/2018/9369358
pmid
29682102
authors array · 3 items
[0]
Junjeong Choi
[1]
Eun-Sol Kim
[2]
Ja Seung Koo
journal
Disease markers
year
2018
abstract
PURPOSE: The purpose of this study was to assess the expression of pentose phosphate pathway- (PPP-) related proteins and their significance in clinicopathologic factors of breast cancer. METHODS: Immunohistochemical staining for PPP-related proteins (glucose-6-phosphate dehydrogenase [G6PDH], 6-phosphogluconolactonase [6PGL], 6-phosphogluconate dehydrogenase [6PGDH], and nuclear factor-erythroid 2-related factor 2 [NRF2]) was performed using tissue microarray (TMA) of 348 breast cancers. mRNA levels of these markers in publicly available data from the Cancer Genome Atlas project and Kaplan-Meier plotters were analyzed. RESULTS: Expression of G6PDH and 6PGL was higher in HER-2 type (p < 0.001 and p = 0.009, resp.) and lower in luminal A type. 6PGDH expression was detected only in TNBC subtype (p < 0.001). G6PDH positivity was associated with ER negativity (p = 0.001), PR negativity (p = 0.001), and HER-2 positivity (p < 0.001), whereas 6PGL positivity was associated with higher T stage (p = 0.004). The 562 expression profile from the TCGA database revealed increased expression of G6PDH and 6PG in the tumor compared with normal adjacent breast tissue. The expression of G6PDH was highest in HER-2 type. HER-2 and basal-like subtypes showed higher expression of 6PGDH than luminal types. CONCLUSION: PPP-related proteins are differentially expressed in breast cancer according to molecular subtype, and higher expression of G6PDH and 6PGL was noted in HER-2 subtype.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
Multivariate regression analysis was performed using the Cox proportional hazard model.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:29682102
locator
sections[9] "2.7. Statistical Analysis" paragraph 2
quote
Multivariate regression analysis was performed using the Cox proportional hazard model.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
We obtained clinical information and level 3 normalized gene expression (RSEM) values from RNA sequencing data of breast cancer (BRCA) from the Broad Genome Data Analysis Center (GDAC) Firehose server (version 01-28-2016) and filtered out genes with an expression equal to zero in more than 50% of samples.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:29682102
locator
sections[8] "2.6. Validation of Expression of PPP-Related Markers in a Public Database" paragraph 2
quote
We obtained clinical information and level 3 normalized gene expression (RSEM) values from RNA sequencing data of breast cancer (BRCA) from the Broad Genome Data Analysis Center (GDAC) Firehose server (version 01-28-2016) and filtered out genes with an expression equal to zero in more than 50% of samples.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:29682102
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_absent
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
blocked
blocked_on
method:student_t
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 2 items
[0]
step:run_analysis blocked on method:student_t
[1]
step:obtain_source_data blocked on data:accession_absent
data object · 3 fields
state
partial
assets array · 5 items
[0] object · 15 fields
id
source:pmid:29682102
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1155/2018/9369358
sha256
sha256:3a9a9218cdc75747a9edd40b3672730000f1ff3d0379477a3ff1947dd74fe3dc
bytes
29002
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1155/2018/9369358
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC5845514
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 16 fields
id
asset:table:pmid:29682102:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:8a0e9b4e5a910fbb4857180370f7885656712dc972fc6710c77fa89c9966f769
bytes
920
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[5]/table-wrap[1]#tab1
version
null
note
Source, clone, and dilution of antibodies.
structure object · 5 fields
pmcid
PMC5845514
section_index
5
section_title
2.3. Immunohistochemistry
row_count
11
column_count
5
table object · 8 fields
label
Table 1
caption
Source, clone, and dilution of antibodies.
rows array · 11 items
[0] array · 5 items
[0]
Antibody
[1]
Company
[2]
Reaction site
[3]
Clone
[4]
Dilution
[1] array · 4 items
[0]
Pentose phosphate pathway-related proteins
[1]
[2]
[3]
[2] array · 5 items
[0]
G6PDH
[1]
Abcam, Cambridge, UK
[2]
Cytoplasmic
[3]
Polyclonal
[4]
1 : 100
[3] array · 5 items
[0]
6PGL
[1]
Abcam, Cambridge, UK
[2]
Cytoplasmic and nuclear
[3]
ERP1238 (B)
[4]
1 : 200
[4] array · 5 items
[0]
6PGDH
[1]
Abcam, Cambridge, UK
[2]
Cytoplasmic
[3]
Polyclonal
[4]
1 : 100
[5] array · 5 items
[0]
NRF2
[1]
Abcam, Cambridge, UK
[2]
Cytoplasmic and nuclear
[3]
Polyclonal
[4]
1 : 50
[6] array · 4 items
[0]
Molecular subtype-related proteins
[1]
[2]
[3]
[7] array · 5 items
[0]
ER
[1]
Thermo Scientific, San Diego, CA, USA
[2]
Nuclear
[3]
SP1
[4]
1 : 100
[8] array · 5 items
[0]
PR
[1]
DAKO, Glostrup, Denmark
[2]
Nuclear
[3]
PgR
[4]
1 : 50
[9] array · 5 items
[0]
HER-2
[1]
DAKO, Glostrup, Denmark
[2]
Membranous
[3]
Polyclonal
[4]
1 : 1500
[10] array · 5 items
[0]
Ki-67
[1]
Abcam, Cambridge, UK
[2]
Nuclear
[3]
MIB
[4]
1 : 1000
locator
section[5]/table-wrap[1]#tab1
[2] object · 16 fields
id
asset:table:pmid:29682102:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:e1541016356015164234bad308b50d27173f6a6aa93c62d389958802514f0468
bytes
1907
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[1]#tab2
version
null
note
Clinicopathologic characteristics of patients according to breast cancer phenotype.
structure object · 5 fields
pmcid
PMC5845514
section_index
11
section_title
3.1. Basal Characteristics of Breast Cancer
row_count
25
column_count
7
table object · 8 fields
label
Table 2
caption
Clinicopathologic characteristics of patients according to breast cancer phenotype.
rows array · 25 items
[0] array · 7 items
[0]
Parameter
[1]
Total(n = 348)(%)
[2]
Luminal A(n = 162)(%)
[3]
Luminal B(n = 84)(%)
[4]
HER-2(n = 27)(%)
[5]
TNBC(n = 75)(%)
[6]
p value
[1] array · 7 items
[0]
Age (years)
[1]
[2]
[3]
[4]
[5]
[6]
0.299
[2] array · 7 items
[0]
≤50
[1]
202 (58.0)
[2]
94 (58.0)
[3]
55 (65.5)
[4]
13 (48.1)
[5]
40 (53.3)
[6]
[3] array · 7 items
[0]
>50
[1]
146 (42.0)
[2]
68 (42.0)
[3]
29 (34.5)
[4]
14 (51.9)
[5]
35 (46.7)
[6]
[4] array · 7 items
[0]
Histologic grade
[1]
[2]
[3]
[4]
[5]
[6]
<0.001
[5] array · 7 items
[0]
I/II
[1]
242 (69.5)
[2]
147 (90.7)
[3]
53 (63.1)
[4]
12 (44.4)
[5]
30 (40.0)
[6]
[6] array · 7 items
[0]
III
[1]
106 (30.5)
[2]
15 (9.3)
[3]
31 (36.9)
[4]
15 (55.6)
[5]
45 (60.0)
[6]
[7] array · 7 items
[0]
Tumor stage
[1]
[2]
[3]
[4]
[5]
[6]
0.068
[8] array · 7 items
[0]
T1
[1]
182 (52.3)
[2]
96 (59.3)
[3]
42 (50.0)
[4]
13 (48.1)
[5]
31 (41.3)
[6]
[9] array · 7 items
[0]
T2/T3
[1]
166 (47.7)
[2]
66 (40.7)
[3]
42 (50.0)
[4]
14 (51.9)
[5]
44 (58.7)
[6]
[10] array · 7 items
[0]
Nodal metastasis
[1]
[2]
[3]
[4]
[5]
[6]
0.676
[11] array · 7 items
[0]
Absent
[1]
208 (59.8)
[2]
94 (58.0)
[3]
48 (57.1)
[4]
17 (63.0)
[5]
49 (65.3)
[6]
[12] array · 7 items
[0]
Present
[1]
140 (40.2)
[2]
68 (42.0)
[3]
36 (42.9)
[4]
10 (37.0)
[5]
26 (34.7)
[6]
[13] array · 7 items
[0]
Estrogen receptor status
[1]
[2]
[3]
[4]
[5]
[6]
<0.001
[14] array · 7 items
[0]
Negative
[1]
107 (30.7)
[2]
2 (1.2)
[3]
3 (3.6)
[4]
27 (100.0)
[5]
75 (100.0)
[6]
[15] array · 7 items
[0]
Positive
[1]
241 (69.3)
[2]
160 (98.8)
[3]
81 (96.4)
[4]
0 (0.0)
[5]
0 (0.0)
[6]
[16] array · 7 items
[0]
Progesterone receptor status
[1]
[2]
[3]
[4]
[5]
[6]
<0.001
[17] array · 7 items
[0]
Negative
[1]
149 (42.8)
[2]
20 (12.3)
[3]
27 (32.1)
[4]
27 (100.0)
[5]
75 (100.0)
[6]
[18] array · 7 items
[0]
Positive
[1]
199 (57.2)
[2]
142 (87.7)
[3]
57 (67.9)
[4]
0 (0.0)
[5]
0 (0.0)
[6]
[19] array · 7 items
[0]
HER-2 status
[1]
[2]
[3]
[4]
[5]
[6]
<0.001
[20] array · 7 items
[0]
Negative
[1]
280 (80.5)
[2]
162 (100.0)
[3]
43 (51.2)
[4]
0 (0.0)
[5]
75 (100.0)
[6]
[21] array · 7 items
[0]
Positive
[1]
68 (19.5)
[2]
0 (0.0)
[3]
41 (48.8)
[4]
27 (100.0)
[5]
0 (0.0)
[6]
[22] array · 7 items
[0]
Ki-67 LI (%)
[1]
[2]
[3]
[4]
[5]
[6]
<0.001
[23] array · 7 items
[0]
≤14
[1]
213 (61.2)
[2]
162 (100.0)
[3]
24 (28.6)
[4]
13 (48.1)
[5]
14 (18.7)
[6]
[24] array · 7 items
[0]
>14
[1]
135 (38.8)
[2]
0 (0.0)
[3]
60 (71.4)
[4]
14 (51.9)
[5]
61 (81.3)
[6]
locator
section[11]/table-wrap[1]#tab2
[3] object · 16 fields
id
asset:table:pmid:29682102:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:78ce38433979c22f61876c9eee5858c8301461863e3e25cb1b482aefa5713f43
bytes
1126
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[1]#tab3
version
null
note
Expression of pentose phosphate pathway-related metabolism-related proteins according to breast cancer subtype.
structure object · 5 fields
pmcid
PMC5845514
section_index
12
section_title
3.2. Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer
row_count
13
column_count
7
table object · 8 fields
label
Table 3
caption
Expression of pentose phosphate pathway-related metabolism-related proteins according to breast cancer subtype.
rows array · 13 items
[0] array · 7 items
[0]
Parameter
[1]
Total(n = 348)(%)
[2]
Luminal A(n = 162)(%)
[3]
Luminal B(n = 84)(%)
[4]
HER-2(n = 27)(%)
[5]
TNBC(n = 75)(%)
[6]
p value
[1] array · 7 items
[0]
G6PDH
[1]
[2]
[3]
[4]
[5]
[6]
<0.001
[2] array · 7 items
[0]
Negative
[1]
297 (85.3)
[2]
149 (92.0)
[3]
70 (83.3)
[4]
14 (51.9)
[5]
64 (85.3)
[6]
[3] array · 7 items
[0]
Positive
[1]
51 (14.7)
[2]
13 (8.0)
[3]
14 (16.7)
[4]
13 (48.1)
[5]
11 (14.7)
[6]
[4] array · 7 items
[0]
6PGL
[1]
[2]
[3]
[4]
[5]
[6]
0.009
[5] array · 7 items
[0]
Negative
[1]
261 (75.0)
[2]
133 (82.1)
[3]
58 (69.0)
[4]
15 (55.6)
[5]
55 (73.3)
[6]
[6] array · 7 items
[0]
Positive
[1]
87 (25.0)
[2]
29 (17.9)
[3]
26 (31.0)
[4]
12 (44.4)
[5]
20 (26.7)
[6]
[7] array · 7 items
[0]
6PGDH
[1]
[2]
[3]
[4]
[5]
[6]
<0.001
[8] array · 7 items
[0]
Negative
[1]
343 (98.6)
[2]
162 (100.0)
[3]
84 (100.0)
[4]
27 (100.0)
[5]
70 (93.3)
[6]
[9] array · 7 items
[0]
Positive
[1]
5 (1.4)
[2]
0 (0.0)
[3]
0 (0.0)
[4]
0 (0.0)
[5]
5 (6.7)
[6]
[10] array · 7 items
[0]
NRF2
[1]
[2]
[3]
[4]
[5]
[6]
0.894
[11] array · 7 items
[0]
Negative
[1]
311 (89.4)
[2]
145 (89.5)
[3]
76 (90.5)
[4]
23 (85.2)
[5]
67 (89.3)
[6]
[12] array · 7 items
[0]
Positive
[1]
37 (10.6)
[2]
17 (10.5)
[3]
8 (9.5)
[4]
4 (14.8)
[5]
8 (10.7)
[6]
locator
section[12]/table-wrap[1]#tab3
[4] object · 16 fields
id
asset:table:pmid:29682102:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:a614bc3cd8aaff51a990712df2ddbc66a4c92009be63539f9f618441d69c0b2e
bytes
1070
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[14]/table-wrap[1]#tab4
version
null
note
Univariate analysis of the impact of expression of pentose phosphate pathway-related proteins in breast cancers on disease-free survival and overall survival by the log-rank test.
structure object · 5 fields
pmcid
PMC5845514
section_index
14
section_title
3.4. The Impact of Expression of Pentose Phosphate Pathway-Related Proteins on Patient Prognosis
row_count
14
column_count
6
table object · 8 fields
label
Table 4
caption
Univariate analysis of the impact of expression of pentose phosphate pathway-related proteins in breast cancers on disease-free survival and overall survival by the log-rank test.
rows array · 14 items
[0] array · 4 items
[0]
Parameter
[1]
Number of patients/recurrence/death
[2]
Disease-free survival
[3]
Overall survival
[1] array · 4 items
[0]
Mean survival (95% CI) months
[1]
p value
[2]
Mean survival (95% CI) months
[3]
p value
[2] array · 6 items
[0]
G6PDH
[1]
[2]
[3]
0.752
[4]
[5]
0.377
[3] array · 6 items
[0]
Negative
[1]
297/28/28
[2]
126 (122–131)
[3]
[4]
129 (125–133)
[5]
[4] array · 6 items
[0]
Positive
[1]
51/4/7
[2]
122 (114–130)
[3]
[4]
120 (109–131)
[5]
[5] array · 6 items
[0]
6PGL
[1]
[2]
[3]
0.239
[4]
[5]
0.569
[6] array · 6 items
[0]
Negative
[1]
261/20/24
[2]
129 (124–133)
[3]
[4]
129 (124–133)
[5]
[7] array · 6 items
[0]
Positive
[1]
87/12/11
[2]
116 (109–124)
[3]
[4]
125 (117–133)
[5]
[8] array · 6 items
[0]
6PGDH
[1]
[2]
[3]
n/a
[4]
[5]
n/a
[9] array · 6 items
[0]
Negative
[1]
343/32/35
[2]
n/a
[3]
[4]
n/a
[5]
[10] array · 6 items
[0]
Positive
[1]
5/0/0
[2]
n/a
[3]
[4]
n/a
[5]
[11] array · 6 items
[0]
NRF2
[1]
[2]
[3]
n/a
[4]
[5]
n/a
[12] array · 6 items
[0]
Negative
[1]
311/32/35
[2]
n/a
[3]
[4]
n/a
[5]
[13] array · 6 items
[0]
Positive
[1]
37/0/0
[2]
n/a
[3]
[4]
n/a
[5]
locator
section[14]/table-wrap[1]#tab4
gaps array · 0 items
analysis object · 4 fields
state
partial
methods array · 5 items
[0] object · 10 fields
id
method-1
family
group_comparison
specific
student_t_test
label
Group comparison
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
student_t
expressible
false
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
0.8
band
high
quote
Student's t-test
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Kaplan-Meier
[2] object · 10 fields
id
method-3
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
log-rank
[3] object · 10 fields
id
method-4
family
contingency_analysis
specific
fisher_exact
label
Categorical (contingency table) analysis
dsl_operations array · 2 items
[0]
contingency_table
[1]
chi_square_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
categorical_cross_tabulation
evidence object · 3 fields
score
0.8
band
high
quote
Fisher's exact
[4] object · 10 fields
id
method-5
family
null
specific
null
label
Cox proportional hazard model
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
Multivariate regression analysis was performed using the Cox proportional hazard model.
targets array · 0 items
gaps array · 2 items
[0]
method.reader_named_unmapped
[1]
method.student_t
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
false
required_operations array · 0 items
missing_operations array · 1 item
[0]
student_t
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: student_t_test.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 0 items
resolved_accessions array · 0 items
statements array · 1 item
[0]
We obtained clinical information and level 3 normalized gene expression (RSEM) values from RNA sequencing data of breast cancer (BRCA) from the Broad Genome Data Analysis Center (GDAC) Firehose server (version 01-28-2016) and filtered out genes with an expression equal to zero in more than 50% of samples.
basis
The paper names no accession to its source data, so the data has to come from the authors.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 5 items
[0]
source:pmid:29682102
[1]
asset:table:pmid:29682102:1
[2]
asset:table:pmid:29682102:2
[3]
asset:table:pmid:29682102:3
[4]
asset:table:pmid:29682102:4
steps array · 0 items
must_build object · 5 fields
dsl_operations array · 1 item
[0] object · 3 fields
operation
student_t
priority
null
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:None
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
null
independence
same_provider
evidence_check object · 2 fields
method
verbatim
availability
null
calls
0
usage object · 0 fields
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:29682102
type
paper
label
pmid:29682102
[1] object · 3 fields
id
source:pmid:29682102
type
manuscript
label
PMID 29682102 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:29682102
type
paper
label
pmid:29682102
[1] object · 3 fields
id
source:pmid:29682102
type
manuscript
label
PMID 29682102 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-29682102
type
extraction
used array · 1 item
[0]
source:pmid:29682102
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-None
type
accession_resolution
used array · 1 item
[0]
data:geo:None
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:29682102
parent_hash
sha256:bd12ea1484b675835afacd6800f739fc7277e494d8c551f8ad1789f2a2998f06
fork_of
null
gaps array · 8 items
[0]
execution.not_run
[1]
method.reader_named_unmapped
[2]
method.student_t
[3]
review.human_critique
[4]
review.independent_reader
[5]
review.machine_critique
[6]
step:obtain_source_data blocked on data:accession_absent
[7]
step:run_analysis blocked on method:student_t
assays array · 3 items
[0] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 1 item
[0]
athologic factors of breast cancer. METHODS: Immunohistochemical staining for PPP-related proteins (glucose-6
order_basis
paper_text_order:227
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
microarray
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 1 item
[0]
factor 2 [NRF2]) was performed using tissue microarray (TMA) of 348 breast cancers. mRNA levels of
order_basis
paper_text_order:485
id
assay:2
[2] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Student's t-test
order_basis
consumes_earlier_output
id
assay:3
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:29682102", "kind": "science-record", "revision": 7, "content_hash": "sha256:9eb2584f04abb9d54d131e7aa911914c9679d989a9e4250a953fcae48df649bb", "created_at": "2026-11-01T15:40:33Z", "updated_at": "2026-11-01T21:59:48Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer.", "doi": "10.1155/2018/9369358", "pmid": "29682102", "authors": ["Junjeong Choi", "Eun-Sol Kim", "Ja Seung Koo"], "journal": "Disease markers", "year": 2018, "abstract": "PURPOSE: The purpose of this study was to assess the expression of pentose phosphate pathway- (PPP-) related proteins and their significance in clinicopathologic factors of breast cancer.\nMETHODS: Immunohistochemical staining for PPP-related proteins (glucose-6-phosphate dehydrogenase [G6PDH], 6-phosphogluconolactonase [6PGL], 6-phosphogluconate dehydrogenase [6PGDH], and nuclear factor-erythroid 2-related factor 2 [NRF2]) was performed using tissue microarray (TMA) of 348 breast cancers. mRNA levels of these markers in publicly available data from the Cancer Genome Atlas project and Kaplan-Meier plotters were analyzed.\nRESULTS: Expression of G6PDH and 6PGL was higher in HER-2 type (p < 0.001 and p = 0.009, resp.) and lower in luminal A type. 6PGDH expression was detected only in TNBC subtype (p < 0.001). G6PDH positivity was associated with ER negativity (p = 0.001), PR negativity (p = 0.001), and HER-2 positivity (p < 0.001), whereas 6PGL positivity was associated with higher T stage (p = 0.004). The 562 expression profile from the TCGA database revealed increased expression of G6PDH and 6PG in the tumor compared with normal adjacent breast tissue. The expression of G6PDH was highest in HER-2 type. HER-2 and basal-like subtypes showed higher expression of 6PGDH than luminal types.\nCONCLUSION: PPP-related proteins are differentially expressed in breast cancer according to molecular subtype, and higher expression of G6PDH and 6PGL was noted in HER-2 subtype.", "claims": [{"id": "claim-method", "statement": "Multivariate regression analysis was performed using the Cox proportional hazard model.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:29682102", "locator": "sections[9] \"2.7. Statistical Analysis\" paragraph 2", "quote": "Multivariate regression analysis was performed using the Cox proportional hazard model."}], "state": "complete"}, {"id": "claim-data-access", "statement": "We obtained clinical information and level 3 normalized gene expression (RSEM) values from RNA sequencing data of breast cancer (BRCA) from the Broad Genome Data Analysis Center (GDAC) Firehose server (version 01-28-2016) and filtered out genes with an expression equal to zero in more than 50% of samples.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:29682102", "locator": "sections[8] \"2.6. Validation of Expression of PPP-Related Markers in a Public Database\" paragraph 2", "quote": "We obtained clinical information and level 3 normalized gene expression (RSEM) values from RNA sequencing data of breast cancer (BRCA) from the Broad Genome Data Analysis Center (GDAC) Firehose server (version 01-28-2016) and filtered out genes with an expression equal to zero in more than 50% of samples."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:29682102"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "blocked", "blocked_on": "method:student_t", "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:run_analysis blocked on method:student_t", "step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:29682102", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1155/2018/9369358", "sha256": "sha256:3a9a9218cdc75747a9edd40b3672730000f1ff3d0379477a3ff1947dd74fe3dc", "bytes": 29002, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1155/2018/9369358", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC5845514", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "asset:table:pmid:29682102:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:8a0e9b4e5a910fbb4857180370f7885656712dc972fc6710c77fa89c9966f769", "bytes": 920, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[5]/table-wrap[1]#tab1", "version": null, "note": "Source, clone, and dilution of antibodies.", "structure": {"pmcid": "PMC5845514", "section_index": 5, "section_title": "2.3. Immunohistochemistry", "row_count": 11, "column_count": 5}, "table": {"label": "Table 1", "caption": "Source, clone, and dilution of antibodies.", "rows": [["Antibody", "Company", "Reaction site", "Clone", "Dilution"], ["Pentose phosphate pathway-related proteins", "", "", ""], ["G6PDH", "Abcam, Cambridge, UK", "Cytoplasmic", "Polyclonal", "1 : 100"], ["6PGL", "Abcam, Cambridge, UK", "Cytoplasmic and nuclear", "ERP1238 (B)", "1 : 200"], ["6PGDH", "Abcam, Cambridge, UK", "Cytoplasmic", "Polyclonal", "1 : 100"], ["NRF2", "Abcam, Cambridge, UK", "Cytoplasmic and nuclear", "Polyclonal", "1 : 50"], ["Molecular subtype-related proteins", "", "", ""], ["ER", "Thermo Scientific, San Diego, CA, USA", "Nuclear", "SP1", "1 : 100"], ["PR", "DAKO, Glostrup, Denmark", "Nuclear", "PgR", "1 : 50"], ["HER-2", "DAKO, Glostrup, Denmark", "Membranous", "Polyclonal", "1 : 1500"], ["Ki-67", "Abcam, Cambridge, UK", "Nuclear", "MIB", "1 : 1000"]], "row_count": 11, "column_count": 5, "numeric_cells": 13, "header_rows": 1, "locator": "section[5]/table-wrap[1]#tab1"}}, {"id": "asset:table:pmid:29682102:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:e1541016356015164234bad308b50d27173f6a6aa93c62d389958802514f0468", "bytes": 1907, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[1]#tab2", "version": null, "note": "Clinicopathologic characteristics of patients according to breast cancer phenotype.", "structure": {"pmcid": "PMC5845514", "section_index": 11, "section_title": "3.1. Basal Characteristics of Breast Cancer", "row_count": 25, "column_count": 7}, "table": {"label": "Table 2", "caption": "Clinicopathologic characteristics of patients according to breast cancer phenotype.", "rows": [["Parameter", "Total(n = 348)(%)", "Luminal A(n = 162)(%)", "Luminal B(n = 84)(%)", "HER-2(n = 27)(%)", "TNBC(n = 75)(%)", "p value"], ["Age (years)", "", "", "", "", "", "0.299"], ["≤50", "202 (58.0)", "94 (58.0)", "55 (65.5)", "13 (48.1)", "40 (53.3)", ""], [">50", "146 (42.0)", "68 (42.0)", "29 (34.5)", "14 (51.9)", "35 (46.7)", ""], ["Histologic grade", "", "", "", "", "", "<0.001"], ["I/II", "242 (69.5)", "147 (90.7)", "53 (63.1)", "12 (44.4)", "30 (40.0)", ""], ["III", "106 (30.5)", "15 (9.3)", "31 (36.9)", "15 (55.6)", "45 (60.0)", ""], ["Tumor stage", "", "", "", "", "", "0.068"], ["T1", "182 (52.3)", "96 (59.3)", "42 (50.0)", "13 (48.1)", "31 (41.3)", ""], ["T2/T3", "166 (47.7)", "66 (40.7)", "42 (50.0)", "14 (51.9)", "44 (58.7)", ""], ["Nodal metastasis", "", "", "", "", "", "0.676"], ["Absent", "208 (59.8)", "94 (58.0)", "48 (57.1)", "17 (63.0)", "49 (65.3)", ""], ["Present", "140 (40.2)", "68 (42.0)", "36 (42.9)", "10 (37.0)", "26 (34.7)", ""], ["Estrogen receptor status", "", "", "", "", "", "<0.001"], ["Negative", "107 (30.7)", "2 (1.2)", "3 (3.6)", "27 (100.0)", "75 (100.0)", ""], ["Positive", "241 (69.3)", "160 (98.8)", "81 (96.4)", "0 (0.0)", "0 (0.0)", ""], ["Progesterone receptor status", "", "", "", "", "", "<0.001"], ["Negative", "149 (42.8)", "20 (12.3)", "27 (32.1)", "27 (100.0)", "75 (100.0)", ""], ["Positive", "199 (57.2)", "142 (87.7)", "57 (67.9)", "0 (0.0)", "0 (0.0)", ""], ["HER-2 status", "", "", "", "", "", "<0.001"], ["Negative", "280 (80.5)", "162 (100.0)", "43 (51.2)", "0 (0.0)", "75 (100.0)", ""], ["Positive", "68 (19.5)", "0 (0.0)", "41 (48.8)", "27 (100.0)", "0 (0.0)", ""], ["Ki-67 LI (%)", "", "", "", "", "", "<0.001"], ["≤14", "213 (61.2)", "162 (100.0)", "24 (28.6)", "13 (48.1)", "14 (18.7)", ""], [">14", "135 (38.8)", "0 (0.0)", "60 (71.4)", "14 (51.9)", "61 (81.3)", ""]], "row_count": 25, "column_count": 7, "numeric_cells": 99, "header_rows": 1, "locator": "section[11]/table-wrap[1]#tab2"}}, {"id": "asset:table:pmid:29682102:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:78ce38433979c22f61876c9eee5858c8301461863e3e25cb1b482aefa5713f43", "bytes": 1126, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#tab3", "version": null, "note": "Expression of pentose phosphate pathway-related metabolism-related proteins according to breast cancer subtype.", "structure": {"pmcid": "PMC5845514", "section_index": 12, "section_title": "3.2. Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer", "row_count": 13, "column_count": 7}, "table": {"label": "Table 3", "caption": "Expression of pentose phosphate pathway-related metabolism-related proteins according to breast cancer subtype.", "rows": [["Parameter", "Total(n = 348)(%)", "Luminal A(n = 162)(%)", "Luminal B(n = 84)(%)", "HER-2(n = 27)(%)", "TNBC(n = 75)(%)", "p value"], ["G6PDH", "", "", "", "", "", "<0.001"], ["Negative", "297 (85.3)", "149 (92.0)", "70 (83.3)", "14 (51.9)", "64 (85.3)", ""], ["Positive", "51 (14.7)", "13 (8.0)", "14 (16.7)", "13 (48.1)", "11 (14.7)", ""], ["6PGL", "", "", "", "", "", "0.009"], ["Negative", "261 (75.0)", "133 (82.1)", "58 (69.0)", "15 (55.6)", "55 (73.3)", ""], ["Positive", "87 (25.0)", "29 (17.9)", "26 (31.0)", "12 (44.4)", "20 (26.7)", ""], ["6PGDH", "", "", "", "", "", "<0.001"], ["Negative", "343 (98.6)", "162 (100.0)", "84 (100.0)", "27 (100.0)", "70 (93.3)", ""], ["Positive", "5 (1.4)", "0 (0.0)", "0 (0.0)", "0 (0.0)", "5 (6.7)", ""], ["NRF2", "", "", "", "", "", "0.894"], ["Negative", "311 (89.4)", "145 (89.5)", "76 (90.5)", "23 (85.2)", "67 (89.3)", ""], ["Positive", "37 (10.6)", "17 (10.5)", "8 (9.5)", "4 (14.8)", "8 (10.7)", ""]], "row_count": 13, "column_count": 7, "numeric_cells": 51, "header_rows": 1, "locator": "section[12]/table-wrap[1]#tab3"}}, {"id": "asset:table:pmid:29682102:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:a614bc3cd8aaff51a990712df2ddbc66a4c92009be63539f9f618441d69c0b2e", "bytes": 1070, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[14]/table-wrap[1]#tab4", "version": null, "note": "Univariate analysis of the impact of expression of pentose phosphate pathway-related proteins in breast cancers on disease-free survival and overall survival by the log-rank test.", "structure": {"pmcid": "PMC5845514", "section_index": 14, "section_title": "3.4. The Impact of Expression of Pentose Phosphate Pathway-Related Proteins on Patient Prognosis", "row_count": 14, "column_count": 6}, "table": {"label": "Table 4", "caption": "Univariate analysis of the impact of expression of pentose phosphate pathway-related proteins in breast cancers on disease-free survival and overall survival by the log-rank test.", "rows": [["Parameter", "Number of patients/recurrence/death", "Disease-free survival", "Overall survival"], ["Mean survival (95% CI) months", "p value", "Mean survival (95% CI) months", "p value"], ["G6PDH", "", "", "0.752", "", "0.377"], ["Negative", "297/28/28", "126 (122–131)", "", "129 (125–133)", ""], ["Positive", "51/4/7", "122 (114–130)", "", "120 (109–131)", ""], ["6PGL", "", "", "0.239", "", "0.569"], ["Negative", "261/20/24", "129 (124–133)", "", "129 (124–133)", ""], ["Positive", "87/12/11", "116 (109–124)", "", "125 (117–133)", ""], ["6PGDH", "", "", "n/a", "", "n/a"], ["Negative", "343/32/35", "n/a", "", "n/a", ""], ["Positive", "5/0/0", "n/a", "", "n/a", ""], ["NRF2", "", "", "n/a", "", "n/a"], ["Negative", "311/32/35", "n/a", "", "n/a", ""], ["Positive", "37/0/0", "n/a", "", "n/a", ""]], "row_count": 14, "column_count": 6, "numeric_cells": 24, "header_rows": 2, "locator": "section[14]/table-wrap[1]#tab4"}}], "gaps": []}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "student_t_test", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["student_t"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "Student's t-test"}}, {"id": "method-2", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Kaplan-Meier"}}, {"id": "method-3", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "log-rank"}}, {"id": "method-4", "family": "contingency_analysis", "specific": "fisher_exact", "label": "Categorical (contingency table) analysis", "dsl_operations": ["contingency_table", "chi_square_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["categorical_cross_tabulation"], "evidence": {"score": 0.8, "band": "high", "quote": "Fisher's exact"}}, {"id": "method-5", "family": null, "specific": null, "label": "Cox proportional hazard model", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Multivariate regression analysis was performed using the Cox proportional hazard model."}}], "targets": [], "gaps": ["method.reader_named_unmapped", "method.student_t"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": false, "required_operations": [], "missing_operations": ["student_t"], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: student_t_test."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": [], "resolved_accessions": [], "statements": ["We obtained clinical information and level 3 normalized gene expression (RSEM) values from RNA sequencing data of breast cancer (BRCA) from the Broad Genome Data Analysis Center (GDAC) Firehose server (version 01-28-2016) and filtered out genes with an expression equal to zero in more than 50% of samples."], "basis": "The paper names no accession to its source data, so the data has to come from the authors."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:29682102", "asset:table:pmid:29682102:1", "asset:table:pmid:29682102:2", "asset:table:pmid:29682102:3", "asset:table:pmid:29682102:4"], "steps": []}, "must_build": {"dsl_operations": [{"operation": "student_t", "unlocks_papers": null, "priority": null}], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": null, "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": null}, "calls": 0, "usage": {}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:29682102", "type": "paper", "label": "pmid:29682102"}, {"id": "source:pmid:29682102", "type": "manuscript", "label": "PMID 29682102 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:29682102", "type": "paper", "label": "pmid:29682102"}, {"id": "source:pmid:29682102", "type": "manuscript", "label": "PMID 29682102 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-29682102", "type": "extraction", "used": ["source:pmid:29682102"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:29682102", "parent_hash": "sha256:bd12ea1484b675835afacd6800f739fc7277e494d8c551f8ad1789f2a2998f06", "fork_of": null, "generation": 6}, "gaps": ["execution.not_run", "method.reader_named_unmapped", "method.student_t", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent", "step:run_analysis blocked on method:student_t"], "assays": [{"role": "data_generation", "definition_id": "ihc", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["athologic factors of breast cancer. METHODS: Immunohistochemical staining for PPP-related proteins (glucose-6"], "order_basis": "paper_text_order:227", "id": "assay:1"}, {"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["factor 2 [NRF2]) was performed using tissue microarray (TMA) of 348 breast cancers. mRNA levels of"], "order_basis": "paper_text_order:485", "id": "assay:2"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.8, "evidence": ["Student's t-test"], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}